Telomir Pharmaceuticals Inc. Common Stock (TELO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Telomir Pharmaceuticals I...

    NASDAQ: TELO · Real-Time Price · USD
    1.27
    0.09 (7.63%)
    At close: Sep 04, 2025, 11:30 AM

    Telomir Pharmaceuticals Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -16.53M -13.07M -854.15K -138.13K
    Depreciation & Amortization
    		 4.34M n/a n/a n/a
    Stock-Based Compensation
    		 6.87M n/a n/a n/a
    Other Working Capital
    		 -57.16K -713 n/a n/a
    Other Non-Cash Items
    		 130K 9.1M -385.49K -18.73K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 126.47K 113.84K 385.49K 18.73K
    Operating Cash Flow
    		 -5.07M -3.86M -468.66K -119.4K
    Capital Expenditures
    		 n/a -4 n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a
    Debt Repayment
    		 -101K 3.12M 462.39K n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -396.64K -255.97K 7.69K 119.4K
    Financial Cash Flow
    		 6.34M 3.86M 470.08K 119.4K
    Net Cash Flow
    		 1.26M -188 1.42K n/a
    Free Cash Flow
    		 -5.07M -3.86M -468.66K -119.4K

    Add to Watchlist